Nautilus Biotechnology, Inc. NAUT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -12.17% | -33.56% | -35.98% | -35.93% | -32.54% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -33.47% | -16.06% | -18.54% | -17.97% | -12.40% |
| Operating Income | 33.73% | 16.31% | 18.54% | 17.97% | 12.40% |
| Income Before Tax | 12.78% | 34.62% | 36.63% | 35.82% | 29.87% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 12.78% | 34.62% | 36.63% | 35.82% | 29.87% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 31.63% | 13.95% | 16.86% | 16.64% | 10.53% |
| EBIT | 33.73% | 16.31% | 18.54% | 17.97% | 12.40% |
| EBITDA | 33.41% | 16.04% | 18.53% | 18.05% | 12.43% |
| EPS Basic | 7.29% | 14.43% | 17.31% | 17.19% | 11.15% |
| Normalized Basic EPS | 8.02% | 15.04% | 17.88% | 17.71% | 13.53% |
| EPS Diluted | 7.29% | 14.43% | 17.31% | 17.19% | 11.15% |
| Normalized Diluted EPS | 8.02% | 15.04% | 17.88% | 17.71% | 13.53% |
| Average Basic Shares Outstanding | 0.58% | 0.57% | 0.56% | 0.66% | 0.71% |
| Average Diluted Shares Outstanding | 0.58% | 0.57% | 0.56% | 0.66% | 0.71% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |